Compare RLMD & BZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RLMD | BZH |
|---|---|---|
| Founded | 2004 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 752.1M | 694.0M |
| IPO Year | 2012 | 1995 |
| Metric | RLMD | BZH |
|---|---|---|
| Price | $6.93 | $26.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $12.40 | ★ $32.00 |
| AVG Volume (30 Days) | 869.6K | ★ 924.5K |
| Earning Date | 05-08-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.28 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $13,070.00 | ★ $2,087,739,000.00 |
| Revenue This Year | N/A | $4.36 |
| Revenue Next Year | N/A | $10.79 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 154.83 | N/A |
| 52 Week Low | $0.52 | $17.83 |
| 52 Week High | $8.00 | $28.33 |
| Indicator | RLMD | BZH |
|---|---|---|
| Relative Strength Index (RSI) | 45.89 | 66.04 |
| Support Level | $6.81 | $23.82 |
| Resistance Level | $7.46 | $27.03 |
| Average True Range (ATR) | 0.42 | 1.11 |
| MACD | -0.04 | 0.36 |
| Stochastic Oscillator | 50.17 | 93.24 |
Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.
Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in states and metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the sources of revenue for the company. Its segments involve: West segment that includes Arizona, California, Nevada, and Texas; East segment that includes Delaware, Indiana, Maryland, Tennessee, and Virginia; and Southeast segment which includes Florida, Georgia, North Carolina, and South Carolina.